Intravitreal injections with a low consumption technique have a low infection rate

Le résumé fourni par la source

As intravitreal injections (IVI) have become the most common ophthalmic procedure, streamlined care pathways are required to deliver large numbers of IVI safely, effectively and comfortably. Ophthalmologists use a range of IVI techniques, with some using more personal protective equipment, antiseptics and antibiotics, injected and topical anaesthesia, and disposable sterile equipment for the injection (a high-consumption technique), while others use very few single use items (a relatively lower-consumption technique). The high volume of IVI means that this consumption of single use sterile supplies and medications is an important consideration for both healthcare costs and environmental impact [ 1 , 2 ]. Ophthalmologists need evidence to support their decisions on IVI practice: it is important to demonstrate the safety of low-consumption practices to allow savings to be enjoyed by all [ 3 , 4 ].

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.